Diamond Level Sponsors
We’re a medicine company turning science into healing to make life better for people around the world.
Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world’s most significant health challenges. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: “Take what you find here and make it better and better.”
But we’re not only dedicated to making medicines. We go beyond medicine to deliver innovative clinical trials that reflect the diversity of our world and work to ensure our medicines are accessible and affordable. Learn more at www.lilly.com/who-we-are/about-lilly.
In 1923, the founders of Novo Nordisk began a journey to change diabetes. Today, we are thousands of employees across the world with the passion, the skills and the commitment to continue this journey to prevent, treat and ultimately cure diabetes. Novo Nordisk is proud to be a Bronze Level Sponsor of the Friends for Life conference. Please come see us at the exhibition to find out more about our company and our products. To learn more about Novo Nordisk and our support to the type 1 diabetes community, visit us at www.novonordisk-us.com.
Gold Level Sponsors
Abbott is a global healthcare leader helping people live more fully at all stages of life. Our FreeStyle Libre portfolio has changed the lives of more than 5.5 million people across more than 60 countries because it is simple, effective and affordable. We’re proud to sponsor the Friends for Life Orlando Conference, raising awareness for diabetes technology to help the 352,000 children and adolescents living with the condition in the U.S. today. Connect with us at https://freestyle.abbott/cwd, on Instagram at @FreeStyleDiabetes, and on Facebook at @FreeStyleUS.
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.
Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s latest innovation, the Omnipod® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and is fully controlled by a compatible personal smartphone. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.
Tandem Diabetes Care creates new possibilities for people living with diabetes, their loved ones, and their healthcare providers through a positively different experience. We deliver innovative products and automated insulin delivery systems — including Tandem Mobi and the t:slim X2 — to people who require insulin therapy. For more information, visit tandemdiabetes.com.
Bronze Level Sponsors
Medtronic Diabetes is on a mission to alleviate the burden of diabetes by empowering individuals to live life on their terms, with the most advanced technology and always-on support when and how it is needed. Medtronic has pioneered first-of-its-kind innovations for over 40 years and is committed to designing the future of diabetes management through next-generation sensors (CGM), intelligent dosing systems, and the power of data science and AI while always putting the customer experience at the forefront. Today we offer the MiniMed™ 780G insulin pump system, the InPen™ smart insulin pen and the i-Port Advance™ injection port, and we continue to innovate further. With a renewed focus on creating products that are easy to use, we hope our future technologies will enable people to focus more on life, and not diabetes. To learn more, visit www.medtronicdiabetes.com and follow us on Facebook, Instagram, TikTok, YouTube and LinkedIn.
Xeris Pharmaceuticals, Inc., the maker of Gvoke HypoPen® (glucagon injection), is dedicated to unlocking the potential of glucagon. We believe that our technology can have a profound impact on the lives of patients and their families. That’s why we are proud to be the first to develop liquid glucagon, but that’s just the beginning. We’re also studying how our formulation technology can impact patients with other conditions. We have a persistent drive to pursue solutions that have the potential to change lives. Get to know us and see how our technology is unlocking the potential of today’s medicines at www.xerispharma.com
Friends of CWD
Beta Bionics is a medical technology company focused on the design, development, and commercialization of its iLet Bionic Pancreas in both the single hormone and bi-hormonal configurations. The iLet Bionic Pancreas platform is designed to use adaptive, self-learning, control algorithms, together with continuous glucose monitoring and pump technology, to autonomously compute and administer doses of insulin and/or glucagon and mimic the body’s natural ability to maintain tight glycemic control, relieving some of the burden of living with diabetes. To learn more, visit http://www.betabionics.com.
The Certification Board for Diabetes Care and Education (CBDCE) is a not for profit certifying body that recognizes a number of different health professionals in the United States as having specialized knowledge about diabetes care and education. The organization name and certification designation underwent a change in 2020; you might be more familiar with the National Certification Board for Diabetes Educators or NCBDE and the Certified Diabetes Educator or CDE certification designation. The organization has been around since 1986, and the Certified Diabetes Care and Education Specialist or CDCES credential is seen as the gold standard in the diabetes world. Currently, over 19,900 health professionals hold the CDCES credential. CDCESs are committed and passionate about what the work they do in partnership with people with diabetes and their families and caregivers.
ConvaTec Franchise, Infusion Care, is a global leader within design and manufacturing of infusion set technologies and insertion devices for insulin pump treatment. ConvaTec has researched and developed insulin infusion sets for the treatment of diabetes since the early 1980s, and has production facilities in Denmark and Mexico. At ConvaTec we strive to create better tailor-made solutions for the treatment of diabetes. Both improvement of current and development of future infusion sets are essential parts of our business. Our success is based on experience, knowledge and a close cooperation with a global network of customers, professionals and the people using our products. ConvaTec has been the preferred partner to leading insulin pump companies worldwide since the mid-1980s. Unomedical a/s is the legal manufacturer of the infusion care product range. For further information about ConvaTec and our products, please visit our website at https://www.convatec.com/infusion-care/infusion-care-diabetes/.
Diabeloop gathers the personality, passion, and skills of over 100 talented individuals, many of whom are personally touched by insulin-dependent diabetes. Founded in Grenoble, France in 2015, Diabeloop is a high-growth company that is developing AI-based, personalized solutions to improve clinical outcomes for people with diabetes while relieving their constant mental burden.
One of the first sponsors of Children with Diabetes in their very first year, the Diabetes Research Institute and Foundation (DRI/F) are proud to, once again, be a part of this important educational and fun event for those affected by diabetes. The Diabetes Research Institute, a Center of Excellence at the University of Miami Miller School of Medicine, leads the world as the largest and most comprehensive research center dedicated to curing diabetes. The DRI is aggressively working to develop a biological cure by restoring natural insulin production. The Diabetes Research Institute and Foundation were created for one reason – to cure diabetes – which is and will continue to be its singular focus until that goal is reached. For more information, please visit www.DiabetesResearch.org or call 800-321-3437.
The JDRF – Beyond Type 1 Alliance provides greater support for those impacted by type 1 diabetes by tapping into the combined power of JDRF, the leading global organization funding T1D research, and Beyond Type 1, the organization with the largest online community of any diabetes nonprofit. The work of the Alliance centers around three core pillars: community programs, advocacy, and communications + education.
With a vision to create a world without limits for people with diabetes, LifeScan is a world leader in blood glucose monitoring – globally more than 20 million people depend on OneTouch brand products to help them manage their diabetes. For over 35 years, LifeScan has had an unwavering commitment to improving the quality of life for people with diabetes by developing products defined by simplicity, accuracy, and trust. For more information, visit www.LifeScan.com and www.OneTouch.com.
Provention Bio, Inc. (Nasdaq: PRVB) is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Company’s pipeline includes a late-stage product candidate for type 1 diabetes (T1D) as well as clinical drug candidates in other autoimmune diseases, including celiac disease and lupus. We are proud to be part of the T1D ecosystem and are committed to bringing awareness to the importance and urgency of screening people with a family history of T1D for early-stage disease. Visit ProventionBio.com for more information or follow us on Twitter: @ProventionBio.
Zealand Pharma A/S was founded in 1998 and is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other rare disease areas with significant unmet medical needs. Zealand employs more than 300 people in Denmark and the US and has a portfolio of medicines and product candidates, including license collaborations with Boehringer Ingelheim.
